CD4 Receptor is a Key Determinant of Divergent HIV-1 Sensing by Plasmacytoid Dendritic Cells

PLoS Pathogens

Volumn 12, Issue 4, 2016, Pages

  O’Brien, Meagan ^a   Manches, Olivier ^a   Wilen, Craig ^b   Gopal, Ramya ^a   Huq, Rumana ^a   Wu, Vernon ^a   Sunseri, Nicole ^c   Bhardwaj, Nina ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; EARLY ENDOSOME ANTIGEN 1; EPITOPE; HEMAGGLUTININ; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; SOLUBLE CD4 ANTIGEN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; CD4 ANTIGEN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYSOSOME; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRAL TROPISM; VIRUS ENVELOPE; ANIMAL; ANTIGEN PRESENTING CELL; C57BL MOUSE; CONFOCAL MICROSCOPY; CYTOLOGY; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; KNOCKOUT MOUSE; VIRION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD4; CELL DIFFERENTIATION; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; VIRION;

EID: 84964890368     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005553     Document Type: Article

References (66)

1. Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, Boritz E, et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature. 2014;511(7511):601–5. doi: 10.1038/nature1355425043006
2. Fenton-May AE, Dibben O, Emmerich T, Ding H, Pfafferott K, Aasa-Chapman MM, et al. Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology. 2013;10:146. doi: 10.1186/1742-4690-10-14624299076
3. Herbeuval JP, Nilsson J, Boasso A, Hardy AW, Kruhlak MJ, Anderson SA, et al. Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(18):7000–5. 16632604
4. Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, Southern PJ, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 2009;458(7241):1034–8. doi: 10.1038/nature0783119262509
5. Haas DW, Lavelle J, Nadler JP, Greenberg SB, Frame P, Mustafa N, et al. A randomized trial of interferon alpha therapy for HIV type 1 infection. AIDS research and human retroviruses. 2000;16(3):183–90. 10710206
6. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science. 2013;340(6129):207–11. doi: 10.1126/science.123521423580529
7. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G, et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science. 2013;340(6129):202–7. doi: 10.1126/science.123520823580528
8. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS pathogens. 2014;10(7):e1004291. doi: 10.1371/journal.ppat.100429125077616
9. Lehmann C, Jung N, Forster K, Koch N, Leifeld L, Fischer J, et al. Longitudinal Analysis of Distribution and Function of Plasmacytoid Dendritic Cells in Peripheral Blood and Gut Mucosa of HIV Infected Patients. The Journal of infectious diseases. 2013.
10. Lehmann C, Lafferty M, Garzino-Demo A, Jung N, Hartmann P, Fatkenheuer G, et al. Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients. PloS one. 2010;5(6):e11110. doi: 10.1371/journal.pone.001111020559432
11. Reeves RK, Evans TI, Gillis J, Wong FE, Kang G, Li Q, et al. SIV Infection Induces Accumulation of Plasmacytoid Dendritic Cells in the Gut Mucosa. The Journal of infectious diseases. 2012.
12. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. The Journal of clinical investigation. 2005;115(11):3265–75. 16224540
13. Pritschet K, Donhauser N, Schuster P, Ries M, Haupt S, Kittan NA, et al. CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells. Virology. 2012;423(2):152–64. doi: 10.1016/j.virol.2011.11.02622209232
14. Lepelley A, Louis S, Sourisseau M, Law HK, Pothlichet J, Schilte C, et al. Innate sensing of HIV-infected cells. PLoS Pathog. 2011;7(2):e1001284. doi: 10.1371/journal.ppat.100128421379343
15. Schmidt B, Scott I, Whitmore RG, Foster H, Fujimura S, Schmitz J, et al. Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation. Virology. 2004;329(2):280–8. 15518808
16. Bloch N, O'Brien M, Norton TD, Polsky SB, Bhardwaj N, Landau NR, HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. AIDS research and human retroviruses. 2014;30(2):195–203. doi: 10.1089/AID.2013.011923924154
17. Hoeffel G, Ripoche AC, Matheoud D, Nascimbeni M, Escriou N, Lebon P, et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity. 2007;27(3):481–92. 17869134
18. Tel J, Schreibelt G, Sittig SP, Mathan TS, Buschow SI, Cruz LJ, et al. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets. Blood. 2013;121(3):459–67. doi: 10.1182/blood-2012-06-43564423212525
19. Lui G, Manches O, Angel J, Molens JP, Chaperot L, Plumas J, Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells. PloS one. 2009;4(9):e7111. doi: 10.1371/journal.pone.000711119771163
20. Tel J, Lambeck AJ, Cruz LJ, Tacken PJ, de Vries IJ, Figdor CG, Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen. Journal of immunology. 2010;184(8):4276–83.
21. Di Pucchio T, Chatterjee B, Smed-Sorensen A, Clayton S, Palazzo A, Montes M, et al. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol. 2008;9(5):551–7. doi: 10.1038/ni.160218376401
22. O'Brien M, Manches O, Sabado RL, Jimenez Baranda S, Wang Y, Marie I, et al. Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-alpha-producing and partially matured phenotype. The Journal of clinical investigation. 2011;121(3):1088–101. doi: 10.1172/JCI4496021339641
23. Manches O, Munn D, Fallahi A, Lifson J, Chaperot L, Plumas J, et al. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. The Journal of clinical investigation. 2008;118(10):3431–9. doi: 10.1172/JCI3482318776940
24. Gilliet M, Cao W, Liu YJ, Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 2008;8(8):594–606. doi: 10.1038/nri235818641647
25. Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, Takaoka A, et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature. 2005;434(7036):1035–40. 15815647
26. Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, et al. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. The Journal of experimental medicine. 2006;203(8):1999–2008. 16864658
27. Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, et al. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol. 2003;170(9):4465–74. 12707322
28. Jaehn PS, Zaenker KS, Schmitz J, Dzionek A, Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon. Eur J Immunol. 2008;38(7):1822–32. doi: 10.1002/eji.20073755218581320
29. Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, et al. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur J Immunol. 2003;33(6):1633–41. 12778481
30. Schmidt B, Ashlock BM, Foster H, Fujimura SH, Levy JA, HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology. 2005;343(2):256–66. 16278001
31. Reszka-Blanco NJ, Sivaraman V, Zhang L, Su L, HIV-1 Env and Nef cooperatively contribute to pDCs activation via CD4-dependent mechanisms. Journal of virology. 2015.
32. Grove J, Marsh M, The cell biology of receptor-mediated virus entry. The Journal of cell biology. 2011;195(7):1071–82. doi: 10.1083/jcb.20110813122123832
33. Sasai M, Linehan MM, Iwasaki A, Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science. 2010;329(5998):1530–4. doi: 10.1126/science.118702920847273
34. Bloom JD, Gong LI, Baltimore D, Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science. 2010;328(5983):1272–5. doi: 10.1126/science.118781620522774
35. Jimenez-Baranda S, Greenbaum B, Manches O, Handler J, Rabadan R, Levine A, et al. Oligonucleotide motifs that disappear during the evolution of influenza virus in humans increase alpha interferon secretion by plasmacytoid dendritic cells. Journal of virology. 2011;85(8):3893–904. doi: 10.1128/JVI.01908-1021307198
36. Pitcher C, Honing S, Fingerhut A, Bowers K, Marsh M, Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the CD4 endocytosis signal by serine phosphorylation. Molecular biology of the cell. 1999;10(3):677–91. 10069811
37. Pelchen-Matthews A, Armes JE, Griffiths G, Marsh M, Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells. The Journal of experimental medicine. 1991;173(3):575–87. 1900077
38. Burgdorf S, Kurts C, Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol. 2008;20(1):89–95. doi: 10.1016/j.coi.2007.12.00218249105
39. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. The Journal of cell biology. 2000;151(3):673–84. 11062267
40. Rohrer J, Schweizer A, Russell D, Kornfeld S, The targeting of Lamp1 to lysosomes is dependent on the spacing of its cytoplasmic tail tyrosine sorting motif relative to the membrane. The Journal of cell biology. 1996;132(4):565–76. 8647888
41. Navaroli DM, Bellve KD, Standley C, Lifshitz LM, Cardia J, Lambright D, et al. Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosis. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(8):E471–80. doi: 10.1073/pnas.111549510922308388
42. Russo C, Cornella-Taracido I, Galli-Stampino L, Jain R, Harrington E, Isome Y, et al. Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cells. Blood. 2011;117(21):5683–91. doi: 10.1182/blood-2010-12-32813821487111
43. Pelchen-Matthews A, Parsons IJ, Marsh M, Phorbol ester-induced downregulation of CD4 is a multistep process involving dissociation from p56lck, increased association with clathrin-coated pits, and altered endosomal sorting. The Journal of experimental medicine. 1993;178(4):1209–22. 8376930
44. Blander JM, Medzhitov R, Regulation of phagosome maturation by signals from toll-like receptors. Science. 2004;304(5673):1014–8. 15143282
45. Keck B, Stoehr R, Wach S, Rogler A, Hofstaedter F, Lehmann J, et al. The plasmacytoid carcinoma of the bladder—rare variant of aggressive urothelial carcinoma. International journal of cancer Journal international du cancer. 2011;129(2):346–54. doi: 10.1002/ijc.2570020878954
46. Palella FJ, Jr.Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. Journal of acquired immune deficiency syndromes. 2006;43(1):27–34. 16878047
47. Yates RM, Russell DG, Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4. Immunity. 2005;23(4):409–17. 16226506
48. Brawand P, Fitzpatrick DR, Greenfield BW, Brasel K, Maliszewski CR, De Smedt T, Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. Journal of immunology. 2002;169(12):6711–9.
49. Bao M, Liu YJ, Regulation of TLR7/9 signaling in plasmacytoid dendritic cells. Protein & cell. 2013;4(1):40–52.
50. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R, TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nature immunology. 2008;9(4):361–8. doi: 10.1038/ni156918297073
51. Sadaka C, Marloie-Provost MA, Soumelis V, Benaroch P, Developmental regulation of MHC II expression and transport in human plasmacytoid-derived dendritic cells. Blood. 2009;113(10):2127–35. doi: 10.1182/blood-2008-10-17815219015396
52. Finkelshtein D, Werman A, Novick D, Barak S, Rubinstein M, LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(18):7306–11. doi: 10.1073/pnas.121444111023589850
53. Guo L, Lu X, Kang SM, Chen C, Compans RW, Yao Q, Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles. Virology. 2003;313(2):502–13. 12954217
54. Young LJ, Wilson NS, Schnorrer P, Proietto A, ten Broeke T, Matsuki Y, et al. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat Immunol. 2008;9(11):1244–52. doi: 10.1038/ni.166518849989
55. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D, Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 1994;76(5):853–64. 8124721
56. daSilva LL, Sougrat R, Burgos PV, Janvier K, Mattera R, Bonifacino JS, Human immunodeficiency virus type 1 Nef protein targets CD4 to the multivesicular body pathway. Journal of virology. 2009;83(13):6578–90. doi: 10.1128/JVI.00548-0919403684
57. Faure J, Stalder R, Borel C, Sobo K, Piguet V, Demaurex N, et al. ARF1 regulates Nef-induced CD4 degradation. Current biology: CB. 2004;14(12):1056–64. 15202998
58. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB, HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell. 2009;137(3):433–44. doi: 10.1016/j.cell.2009.02.04619410541
59. Mouries J, Moron G, Schlecht G, Escriou N, Dadaglio G, Leclerc C, Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood. 2008;112(9):3713–22. doi: 10.1182/blood-2008-03-14629018698004
60. Salio M, Palmowski MJ, Atzberger A, Hermans IF, Cerundolo V, CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J Exp Med. 2004;199(4):567–79. 14970182
61. Yoshimura S, Bondeson J, Foxwell BM, Brennan FM, Feldmann M, Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. International immunology. 2001;13(5):675–83. 11312255
62. West MA, Wallin RP, Matthews SP, Svensson HG, Zaru R, Ljunggren HG, et al. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science. 2004;305(5687):1153–7. 15326355
63. Henault J, Martinez J, Riggs JM, Tian J, Mehta P, Clarke L, et al. Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity. 2012;37(6):986–97. doi: 10.1016/j.immuni.2012.09.01423219390
64. Haupt S, Donhauser N, Chaipan C, Schuster P, Puffer B, Daniels RS, et al. CD4 binding affinity determines human immunodeficiency virus type 1-induced alpha interferon production in plasmacytoid dendritic cells. J Virol. 2008;82(17):8900–5. doi: 10.1128/JVI.00196-0818579609
65. Fonteneau JF, Larsson M, Beignon AS, McKenna K, Dasilva I, Amara A, et al. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol. 2004;78(10):5223–32. 15113904
66. Dunn KW, Kamocka MM, McDonald JH, A practical guide to evaluating colocalization in biological microscopy. American journal of physiology Cell physiology. 2011;300(4):C723–42. doi: 10.1152/ajpcell.00462.201021209361